Antallet af trombotiske/ tromboemboliske hændelser, som blev set i kliniske undersøgelser, var ens for romiplostim og placebo, og der sås ikke en forbindelse mellem
The incidence of thrombotic/ thromboembolic events observed in clinical trials was similar between romiplostim and placebo, and an association between these events and elevated platelet counts was not observed.